Association of C-reactive protein and homocysteine with subclinical coronary plaque subtype and stenosis using low-dose MDCT coronary angiography
- PMID: 20599197
- DOI: 10.1016/j.atherosclerosis.2010.06.017
Association of C-reactive protein and homocysteine with subclinical coronary plaque subtype and stenosis using low-dose MDCT coronary angiography
Abstract
Objectives: Given the uncertainty regarding the relationship of C-reactive protein (CRP) and homocysteine (Hcy) to atherosclerotic burden, our aim was to determine whether CRP and Hcy are related to the presence of subclinical coronary plaque and stenosis.
Methods: We did a cross-sectional analysis of data gathered on 1248 consecutive, newly self-referred, middle-aged subjects who underwent health check ups at China Medical University Hospital. Participants had at least one cardiac risk factor, but no known coronary heart disease. Low-dose multidetector computed tomography coronary angiography (MDCT-CA) was used to measure coronary artery stenosis and identify plaque subtypes.
Results: Subjects were divided into quartiles based on levels of high-sensitivity (hs)-CRP and Hcy. hs-CRP level and Hcy level were associated with the relative proportion of plaque subtypes; Hcy level (P<0.05) but not hs-CRP level (P>0.05) was associated with prevalence of artery segment stenosis. After multivariate adjustment for traditional cardiovascular risk factors through logistic regression analysis, neither hs-CRP level nor Hcy level was independently associated with coronary plaque subtypes and stenosis (P>0.05).
Conclusions: Subclinical atherosclerosis is mildly increased in subjects with higher CRP and Hcy levels, but this association is not independent of traditional cardiovascular risk factors. CRP and Hcy are poor predictors of atherosclerotic burden and coronary stenosis.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Plasma homocysteine predicts progression of atherosclerosis.Atherosclerosis. 2005 Jul;181(1):159-65. doi: 10.1016/j.atherosclerosis.2005.01.001. Atherosclerosis. 2005. PMID: 15939068
-
Association of serum homocysteine levels with the severity and calcification of coronary atherosclerotic plaques detected by coronary CT angiography.Int Angiol. 2014 Aug;33(4):316-23. Int Angiol. 2014. PMID: 25056163
-
Association between high-sensitivity C-reactive protein and coronary plaque subtypes assessed by 64-slice coronary computed tomography angiography in an asymptomatic population.Circ Cardiovasc Imaging. 2011 May;4(3):201-9. doi: 10.1161/CIRCIMAGING.109.929901. Epub 2011 Mar 21. Circ Cardiovasc Imaging. 2011. PMID: 21422167
-
Biochemical Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study.Int J Endocrinol Metab. 2018 Oct 16;16(4 Suppl):e84783. doi: 10.5812/ijem.84783. eCollection 2018 Oct. Int J Endocrinol Metab. 2018. PMID: 30584444 Free PMC article. Review.
-
Glagovian remodelling, plaque composition, and stenosis generation.Heart. 2000 Nov;84(5):461-2. doi: 10.1136/heart.84.5.461. Heart. 2000. PMID: 11039994 Free PMC article. Review. No abstract available.
Cited by
-
Factors associated with coronary heart disease in COPD patients and controls.PLoS One. 2022 Apr 27;17(4):e0265682. doi: 10.1371/journal.pone.0265682. eCollection 2022. PLoS One. 2022. PMID: 35476713 Free PMC article.
-
Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness.Exp Ther Med. 2020 Feb;19(2):1167-1174. doi: 10.3892/etm.2019.8326. Epub 2019 Dec 13. Exp Ther Med. 2020. PMID: 32010285 Free PMC article.
-
Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.Am J Pathol. 2017 Dec;187(12):2895-2911. doi: 10.1016/j.ajpath.2017.08.006. Epub 2017 Nov 16. Am J Pathol. 2017. PMID: 29153655 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous